Jasper Therapeutics, Inc. - 10-Q Filing
Jasper Therapeutics, Inc. reports Q3 2026 financial results including updates on warrant liabilities and equity incentive plan availability.
Tickers: $JSPR
Jasper Therapeutics, Inc. reports Q3 2026 financial results including updates on warrant liabilities and equity incentive plan availability.
Tickers: $JSPR